OPN1SW and Obesity: Based on the health benefits, wide natural occurrence, dietary availability, low toxicity, relatively safe in humans use, and organoprotective properties with a plausible pharmacological affinity, selectivity and potency on different receptors and enzyme and molecular mechanisms targeting signaling pathways involved in glucose and lipid homeostasis, BCP appears to be a promising candidate for use in IR, T2DM, obesity, hyperlipidemia, and diabetic complications.